The latest price target for SBC Medical Group Holding (NASDAQ:SBC) was reported by BTIG on March 6, 2026. The analyst firm set a price target for $8.00 expecting SBC to rise to within 12 months (a possible 115.63% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for SBC Medical Group Holding (NASDAQ:SBC) was provided by BTIG, and SBC Medical Group Holding initiated their buy rating.

There is no last upgrade for SBC Medical Group Holding

There is no last downgrade for SBC Medical Group Holding.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SBC Medical Group Holding, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SBC Medical Group Holding was filed on March 6, 2026 so you should expect the next rating to be made available sometime around March 6, 2027.

While ratings are subjective and will change, the latest SBC Medical Group Holding (SBC) rating was a initiated with a price target of $0.00 to $8.00. The current price SBC Medical Group Holding (SBC) is trading at is $3.71, which is within the analyst’s predicted range.